Merck's RSV Antibody Enflonsia Approved in EU; Researchers Develop Antibody Cocktail Against RSV and hMPV
Merck's Enflonsia (clesrovimab) receives EU approval for RSV prevention in infants. Separately, researchers identify a monoclonal antibody cocktail from pediatricians' immune cells that shows potent protection against RSV and hMPV in animal studies.